Ithappenz Morning After Tablet
Product Images NDC 58602-892

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Ithappenz Morning After (NDC 58602-892). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel -1.5 mg (1 Tablet Carton Label) (Levonorgestrel Fig1)

Package Label-principal Display Panel -1.5 mg (1 Tablet Carton Label) (Levonorgestrel Fig1)
Packaging label for ITHAPPENZ MORNING AFTER levonorgestrel tablet 1.5 mg emergency contraceptive by Aurohealth LLC. The label includes drug facts such as active ingredient, use, warnings, directions, and inactive ingredients. The front panel highlights that it contains one tablet to reduce the chance of pregnancy after unprotected sex, not for regular birth control.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.